SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-089636
Filing Date
2024-08-14
Accepted
2024-08-14 16:15:29
Documents
17
Period of Report
2024-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421702d1_8k.htm   iXBRL 8-K 28329
2 EXHIBIT 99.1 tm2421702d1_ex99-1.htm EX-99.1 50095
7 GRAPHIC tm2421702d1_ex99-1img01.jpg GRAPHIC 3427
8 GRAPHIC tm2421702d1_ex99-1img02.jpg GRAPHIC 2226
  Complete submission text file 0001104659-24-089636.txt   313314

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cycc-20240814.xsd EX-101.SCH 3260
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycc-20240814_def.xml EX-101.DEF 26928
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycc-20240814_lab.xml EX-101.LAB 36551
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycc-20240814_pre.xml EX-101.PRE 25552
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2421702d1_8k_htm.xml XML 5433
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 241208037
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)